TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High

Zhao Chen1, Lifang Tian1, Li Wang1

  • 1Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xincheng District, Xi'an, 710004, Shaanxi Province, China.

Inflammation
|November 16, 2021
PubMed

Insights

Inhibiting Tripartite Motif-Containing Protein 32 (TRIM32) protects kidney podocytes from high glucose (HG) damage by boosting Nrf2 signaling. This discovery offers a new therapeutic target for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic nephropathy is driven by hyperglycemia-induced oxidative stress in podocytes.
  • Tripartite Motif-Containing Protein 32 (TRIM32) regulates apoptosis and oxidative stress.
  • The role of TRIM32 in high glucose (HG)-induced podocyte injury is unknown.

Purpose of the Study:

  • To investigate the role of TRIM32 in HG-induced podocyte injury.
  • To explore the underlying molecular mechanisms involving TRIM32, Akt/GSK-3β, and Nrf2 signaling.

Main Methods:

  • Assessed TRIM32 expression in HG-exposed podocytes and diabetic mouse glomeruli.
  • Performed TRIM32 knockdown experiments in vitro.
  • Investigated the effects on podocyte viability, apoptosis, oxidative stress, and inflammation.
  • Analyzed the involvement of Akt/GSK-3β and Nrf2 signaling pathways.

Main Results:

  • TRIM32 expression increased in HG-exposed podocytes and diabetic glomeruli.
  • TRIM32 knockdown improved podocyte viability and reduced HG-induced apoptosis, oxidative stress, and inflammation.
  • TRIM32 inhibition enhanced Nrf2 signaling activation via the Akt/GSK-3β axis.
  • Akt or Nrf2 suppression abrogated the protective effects of TRIM32 inhibition.

Conclusions:

  • TRIM32 inhibition protects podocytes from HG-induced injury.
  • This protection is mediated by enhancing Nrf2 signaling through the Akt/GSK-3β pathway.
  • TRIM32 is a potential therapeutic target for diabetic nephropathy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
291